May is IRD and Genetic Testing Month at Prevent Blindness, raising awareness of conditions like Stargardt disease and the ...
Prevent Blindness, the nation's leading patient advocacy organization dedicated to protecting and preserving eye health, has ...
Participants were age 39-88 years with no significant demographic differences between the two arms. In the VE arm, 170 (90.95%) participants completed GT versus 49 (77.8%) in the GC arm (P = .01). The ...
Treatment Patterns, Trends, and Outcomes of Neoadjuvant Chemotherapy Use Among Patients With Early-Stage Invasive Triple-Negative Breast Cancer The purpose ot this study was to assess the ...